Search Results - Matthew I. Milowsky

Refine Results
  1. 1
    Advanced bladder cancer: Status of first‐line chemotherapy and the search for active agents in the second‐line setting

    Advanced bladder cancer: Status of first‐line chemotherapy and the search for active agents in the second‐line setting by David Gallagher, Matthew I. Milowsky, Dean F. Bajorin

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Bladder cancer in the elderly

    Bladder cancer in the elderly by Shahrokh F. Shariat, Matthew I. Milowsky, Michael J. Droller

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma

    Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma by David M. Nanus, A. Garino, Matthew I. Milowsky, Maureen Larkin, Janice P. Dutcher

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Active chemotherapy for collecting duct carcinoma of the kidney

    Active chemotherapy for collecting duct carcinoma of the kidney by Matthew I. Milowsky, Alyssa S. Rosmarin, Satish K. Tickoo, Nicholas Papanicolaou, David M. Nanus

    Published 2001
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma

    Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma by Bhavani Krishnan, Tracy L. Rose, Jordan Kardos, Matthew I. Milowsky, William Y. Kim

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Bladder preservation in muscle-invasive bladder cancer: a comprehensive review

    Bladder preservation in muscle-invasive bladder cancer: a comprehensive review by Judy Hamad, Hannah McCloskey, Matthew I. Milowsky, Trevor J. Royce, Angela Smith

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer

    Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer by Tracy L. Rose, Allison M. Deal, Matthew E. Nielsen, Angela Smith, Matthew I. Milowsky

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer

    Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer by Matthew I. Milowsky, David M. Nanus, Lale Kostakoğlu, Shankar Vallabhajosula, Stanley J. Goldsmith, Neil H. Bander

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer

    Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer by Blaine Brower, Asia S. McCoy, Hiba Ahmad, Cheryl Eitman, I. Alex Bowman, Jennifer Rembisz, Matthew I. Milowsky

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer

    Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer by Andrea B. Apolo, Jamie C. Riches, Heiko Schöder, Oğuz Akın, A. Trout, Matthew I. Milowsky, Dean F. Bajorin

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity

    A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity by Daniel J. Crona, Aimee Faso, Tomohiro F. Nishijima, Kathleen A. McGraw, Matthew D. Galsky, Matthew I. Milowsky

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity

    Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity by David C. Johnson, Matthew E. Nielsen, Jonathan Matthews, Michael Woods, Eric Wallen, Raj S. Pruthi, Matthew I. Milowsky, Angela Smith

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Association of hospital volume with conditional 90‐day mortality after cystectomy: an analysis of the <scp>N</scp>ational <scp>C</scp>ancer <scp>D</scp>ata <scp>B</scp>ase

    Association of hospital volume with conditional 90‐day mortality after cystectomy: an analysis of the <scp>N</scp>ational <scp>C</scp>ancer <scp>D</scp>ata <scp>B</scp>ase by Matthew E. Nielsen, Katherine Mallin, Mark A. Weaver, Bryan E. Palis, Andrew K. Stewart, David P. Winchester, Matthew I. Milowsky

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Detection of circulating tumor cells in patients with urothelial cancer

    Detection of circulating tumor cells in patients with urothelial cancer by David Gallagher, Matthew I. Milowsky, Nicole Ishill, A. Trout, M. G. Boyle, Jamie C. Riches, Martin Fleisher, Dean F. Bajorin

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors

    Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors by Matthew I. Milowsky, David M. Nanus, Lale Kostakoğlu, Christine E. Sheehan, Shankar Vallabhajosula, Stanley J. Goldsmith, Jeffrey S. Ross, Neil H. Bander

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer

    Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer by Himisha Beltran, Scott T. Tagawa, Kyung Park, Theresa Y. MacDonald, Matthew I. Milowsky, Juan Miguel Mosquera, Mark A. Rubin, David M. Nanus

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Trends in stage‐specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006

    Trends in stage‐specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006 by Matthew E. Nielsen, Angela Smith, Anne‐Marie Meyer, Tzy‐Mey Kuo, Seth Tyree, William Y. Kim, Matthew I. Milowsky, Raj S. Pruthi, Robert C. Millikan

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Final Results of Sequential Doxorubicin Plus Gemcitabine and Ifosfamide, Paclitaxel, and Cisplatin Chemotherapy in Patients With Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium

    Final Results of Sequential Doxorubicin Plus Gemcitabine and Ifosfamide, Paclitaxel, and Cisplatin Chemotherapy in Patients With Metastatic or Locally Advanced Transitional Cell Ca... by Matthew I. Milowsky, David M. Nanus, Fernando Cotait Maluf, Svetlana Mironov, Weiji Shi, Alexia Iasonos, Jamie C. Riches, Ashley Marie Regazzi, Dean F. Bajorin

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A role for neoadjuvant gemcitabine plus cisplatin in muscle‐invasive urothelial carcinoma of the bladder

    A role for neoadjuvant gemcitabine plus cisplatin in muscle‐invasive urothelial carcinoma of the bladder by Atreya Dash, Joseph A. Pettus, Harry W. Herr, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Paul Russo, Mary G. Boyle, Matthew I. Milowsky, Dean F. Bajorin

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy

    Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy by Andrea B. Apolo, Irina Ostrovnaya, Susan Halabi, Alexia Iasonos, George Philips, Jonathan E. Rosenberg, Jamie C. Riches, Eric J. Small, Matthew I. Milowsky, Dean F. Bajorin

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: